AGP Executive Report
Last update: 11 hours agoRegulatory Overhaul: Massachusetts’ Cannabis Control Commission kicks off a major modernization push Sept. 17, with talks on cannabis testing protocols, medical licensing, and registered agent training. Medical Access Moves: Curaleaf is expanding in Pennsylvania and Connecticut—relocating its Passyunk dispensary to a larger Fishtown site and shifting Hartford to Meriden. Youth & Overdose Risk: A CDC-linked report flags cannabis in 42.7% of adolescent overdose deaths (ages 12–17), with fentanyl in nearly 9 of 10 cases—fueling calls for stronger community prevention. Policy & Oversight: The U.S. House passed “Tyler’s Law,” requiring a study of how often hospitals test for marijuana, fentanyl, and other drugs in emergency rooms. Industry Growth: Minnesota’s Office of Cannabis Management says legal sales topped $250M in the first year, generating $45.6M in tax revenue. Research Watch: UCSF researchers argue psychedelic trials need more convincing placebos to preserve masking and improve results.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
